Azole resistance of Candida glabrata in a case of recurrent fungemia

Journal of Clinical Microbiology

Volumn 44, Issue 8, 2006, Pages 3046-3047

  Posteraro, Brunella ^a   Tumbarello, Mario ^a   La Sorda, Marilena ^a   Spanu, Teresa ^a   Trecarichi, Enrico Maria ^a   De Bernardis, Flavia ^b   Scoppettuolo, Giancarlo ^a   Sanguinetti, Maurizio ^a   Fadda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMPHOTERICIN B DEOXYCHOLATE; CEFTRIAXONE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ADULT; ARTICLE; BLOOD CULTURE; CANDIDA GLABRATA; CASE REPORT; CGCDR1 GENE; CGCDR2 GENE; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; FUNGAL GENE; FUNGEMIA; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENCE; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; AZOLES; BLOOD; CANDIDA GLABRATA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGEMIA; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; HUMANS; RECURRENCE; VAGINA;

CANDIDA GLABRATA;

EID: 33747173089     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00526-06     Document Type: Article

References (15)

1. Barth, T., J. Broscheit, S. Bussen, and J. Dietl. 2002. Maternal sepsis and intrauterine fetal death resulting from Candida tropicalis chorioamnionitis in a woman with a retained intrauterine contraceptive device. Acta Obstet. Gynecol. Scand. 81:981-982.
2. Bennett, J. E., K. Izumikawa, and K. A. Marr. 2004. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents Chemother. 48:1773-1777.
3. Borst, A., M. T. Raimer, D. W. Warnock, C. J. Morrison, and B. A. Arthington-Skaggs. 2005. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob. Agents Chemother. 49:783-787.
4. Cartledge, J. D., J. Midgley, and B. G. Gazzard. 1999. Non-albicans oral candidosis in HIV-positive patients. J. Antimicrob. Chemother. 43:419-422.
5. Dodgson, A. R., C. Pujol, D. W. Denning, D. R. Soil, and A. J. Fox. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41:5709-5717.
6. Maenza, J. R., W. G. Merz, M. J. Romagnoli, J. C. Keruly, R. D. Moore, and J. E. Gallant. 1997. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin. Infect. Dis. 24:28-34.
7. Miyazaki, H., Y. Miyazaki, A. Geber, T. Parkinson, C. Hitchcock, D. Falcone, K. Marsden, and J. E. Bennett. 1998. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42:1695-1701.
8. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Pappas, P. G., J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, T. J. Walsh, J. E. Edwards, and the Infectious Diseases Society of America. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38:161-168.
10. Pfaller, M. A., L. Boyken, S. A. Messer, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2005. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. J. Clin. Microbiol. 43:5208-5213.
11. Redding, S. W., W. R. Kirkpatrick, S. Saville, B. J. Coco, W. White, A. Fothergill, M. Rinaldi, T. Eng, T. F. Patterson, and J. Lopez-Ribot. 2003. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J. Clin. Microbiol. 41:619-622.
12. Sanglard, D., F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
13. Sanguinetti, M., B. Posteraro, B. Fiori, S. Ranno, R. Torelli, and G. Fadda. 2005. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49:668-679.
14. Warren, N. G., and K. C. Hazen. 1999. Candida, Cryptococcus, and other yeasts of medical importance, p. 1184-1199. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
15. Wilson, A. G., S. T. Micek, and D. J. Ritchie. 2005. A retrospective evaluation of fluconazole for the treatment of Candida glabrata fungemia. Clin. Ther. 27:1228-1237.